中
About Weiren Meditech
——
 广东唯仁医疗科技有限公司由“国家重大人才工程”青年项目入选者、知名OCT企业资深研究员等高层次博士人才创立，是一家拥有自主研发专利和技术的国家高新技术企业，专注于高端医疗器械眼科光学相干断层扫描仪（OCT）的研发和生产，目前产品OCT已取得二类医疗器械证，获批“省重大人才工程”科技创新团队、省工程技术研究中心，核心成员由多名国际知名高校博士/博士后构成。

National-level distinguished high-level talents
Selected by the Youth Project of National Major Talent Project
Provincial major talent Project scientific and technological innovation team
Compound talents at home and abroad
National-level distinguished high-level talents
Master the world's advanced optical imaging core technology
The founder is one of the inventors of OCTA technology in the world
Multi-platform cooperation between industry, university and research
High-end optical, electronic, and mechanical laboratories
Multiple university/hospital joint research
Multi-platform cooperation between industry, university and research
Patent 90+ Copyright of computer software 6 Brand 17

Three advantages
————

Cost-effective eye medical products

唯仁医疗专注于高端眼科光学医疗设备的研发与生产，致力于建立完善的眼科影像产品布局。产品线覆盖眼底检查、眼前节检查多种光学设备，核心产品眼科光学相干断层扫描仪 （OCT），其扫描速度与成像深度优势显著，成像性能达到全球 OCT 一流水平，产品极具竞争力。唯仁医疗开发高性价比的眼科成像设备推动高端医疗设备在各级医疗机构眼科临床上的普及应用，促进眼科诊疗水平进步。

AI empowers eye health screening
Weiren Meditechsimultaneously develops AI technology in ophthalmology, develops an OCT/OCTA high-quality imaging system and an intelligent diagnosis cloud platform based on artificial intelligence technology, and uses AI technology to enable equipment and doctors to establish an intelligent system for abnormal screening of eye diseases and diagnosis of diseases. Through the blessing of AI, we will promote the application of eye imaging equipment in multiple scenarios such as medical treatment, physical examination, and optometry to serve the whole process of eye health.
Wide coverage of service network
OCTA series products have been launched in many provinces and cities across the country to provide customers with fast and efficient service and support.The product is currently deployed in dozens of hospitals and medical R&D institutions across the country; the product is based on domestic chips for ophthalmology.AIIndependent research and development of early screening technology, large-scale eye disease physical examination and screening projects have been carried out in dozens of communities across the country, benefiting nearly thousands of middle-aged and elderly people, and the accuracy rate of fundus abnormality detection is ≥97%.